Genenta Science Valuation

GNTA Stock  USD 4.69  0.11  2.29%   
At this time, the firm appears to be undervalued. Genenta Science SpA retains a regular Real Value of $9.09 per share. The prevalent price of the firm is $4.69. Our model calculates the value of Genenta Science SpA from evaluating the firm fundamentals such as Shares Owned By Insiders of 38.68 %, return on asset of -0.26, and Return On Equity of -0.43 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Genenta Science's valuation include:
Price Book
4.8767
Enterprise Value
68.2 M
Enterprise Value Ebitda
(11.48)
Undervalued
Today
4.69
Please note that Genenta Science's price fluctuation is moderately volatile at this time. Calculation of the real value of Genenta Science SpA is based on 3 months time horizon. Increasing Genenta Science's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Genenta Science is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Genenta Stock. However, Genenta Science's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  4.69 Real  9.09 Target  23.0 Hype  4.1 Naive  5.27
The real value of Genenta Stock, also known as its intrinsic value, is the underlying worth of Genenta Science SpA Company, which is reflected in its stock price. It is based on Genenta Science's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Genenta Science's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
9.09
Real Value
15.80
Upside
Estimating the potential upside or downside of Genenta Science SpA helps investors to forecast how Genenta stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Genenta Science more accurately as focusing exclusively on Genenta Science's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.000.000.00
Details
Hype
Prediction
LowEstimatedHigh
0.214.1010.81
Details
Naive
Forecast
LowNext ValueHigh
0.115.2711.99
Details
2 Analysts
Consensus
LowTarget PriceHigh
20.9323.0025.53
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Genenta Science's intrinsic value based on its ongoing forecasts of Genenta Science's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Genenta Science's closest peers. If more than one evaluation category is relevant for Genenta Science we suggest using both methods to arrive at a better estimate.

Genenta Science Cash

3.51 Million

Genenta Valuation Trend

Comparing Genenta Science's enterprise value against its market capitalization is a good way to estimate the value of Genenta Science SpA uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.

Genenta Science Total Value Analysis

Genenta Science SpA is currently anticipated to have valuation of 68.15 M with market capitalization of 85.85 M, debt of 14, and cash on hands of 37.24 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Genenta Science fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
68.15 M
85.85 M
14
37.24 M

Genenta Science Asset Utilization

One of the ways to look at asset utilization of Genenta is to check how much profit was generated for every dollar of assets it reports. Genenta Science retains a negative application of resources of -0.26 (percent), losing $0.002583 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Genenta Science SpA shows how discouraging it operates for each dollar spent on its resources.

Genenta Science Ownership Allocation

Genenta Science SpA has a total of 18.29 Million outstanding shares. Genenta Science secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Genenta Science Profitability Analysis

Net Loss for the year was (11.65 M) with profit before overhead, payroll, taxes, and interest of 0.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Genenta Science's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Genenta Science and how it compares across the competition.

About Genenta Science Valuation

The stock valuation mechanism determines Genenta Science's current worth on a weekly basis. Our valuation model uses a comparative analysis of Genenta Science. We calculate exposure to Genenta Science's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Genenta Science's related companies.
Last ReportedProjected for Next Year
Gross Profit-41.6 K-39.5 K

Genenta Science Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding18.2 M
Shares Float11.2 M

Genenta Science Current Valuation Indicators

Valuation refers to the process of determining the present value of Genenta Science SpA and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Genenta we look at many different elements of the entity such as Genenta's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Genenta Science, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Genenta Science's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Genenta Science's worth.

Complementary Tools for Genenta Stock analysis

When running Genenta Science's price analysis, check to measure Genenta Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genenta Science is operating at the current time. Most of Genenta Science's value examination focuses on studying past and present price action to predict the probability of Genenta Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genenta Science's price. Additionally, you may evaluate how the addition of Genenta Science to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Global Correlations
Find global opportunities by holding instruments from different markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Commodity Directory
Find actively traded commodities issued by global exchanges